Pro-pharma lobbying picks up as pharmacare bill nears final approval

Groups opposed to a single-payer pharmacare plan stage communications blitz

Madison McLauchlan
Read more posts by this author.

Madison McLauchlan

8 July, 2024 • 5 min read

Share this story

An employee places drugs on a shelf inside a pharmacy.

Pharmaceutical manufacturers are intensely lobbying the Canadian government as legislators debate a bill that would lower drug prices for some consumers. (Sue Ogrocki/The Associated Press)

Share this story

Lobby groups representing the pharmaceutical and insurance industries are upping their lobbying activities as national pharmacare legislation inches closer to becoming law.

Pro-pharma lobbying picks up as pharmacare bill nears final approval

Madison McLauchlan

Madison McLauchlan

Continue Reading:

Free

$14.27

‘Quite startling’ wait-lists for addiction treatment in B.C. revealed in new documents

Big Pharma firms lead B.C.’s top 10 list of public contract winners, thanks to pricey cancer drugs

Parties trade blame following IJF investigation into B.C.’s addiction treatment bed numbers

Exploited in the workplace: the ‘Canadian dream’ turns into a nightmare for international students

Canadian movie theatres are meeting with the federal government after GTA cinemas targeted in shootings potentially linked to organized crime